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Abstract
Background: Cactus polysaccharides are the active components of Opuntia dillenii which have been used extensively in folk medicine. In this
study, we investigate the anti-tumor effect of cactus polysaccharides on lung squamous carcinoma cells SK-MES-1.
Materials and Methods: The inhibitory effect of Cactus polysaccharides on lung squamous carcinoma cells were detected by MTT assay. Cell
cycle was determined by flow cytometry and cell apoptosis was determined by AnnexinV assay. Western-blotting was applied to detect P53 and
PTEN protein expression in the cells treated with cactus polysaccharides.
Results: Results showed that different concentrations of wild cactus polysaccharides prevent SK-MES-1 cells growth and induces S phase arrest.
The data also revealed that cactus polysaccharides cause apoptosis in SK-MES-1 cells determined by Annexin-V assay. Furthermore, cactus
polysaccharides induced growth arrest and apoptosis may be due to the increase of P53 and phosphatase and tension homolog deleted on
chromosome ten (PTEN) protein.
Conclusion: Cactus polysaccharides have anti-tumor activity on lung squamous carcinoma cells.
Key words: Cactus polysaccharides, Lung squamous carcinoma, Anti-tumor effect, P53, PTEN
Abbreviations: PTEN :phosphatase and tension homolog deleted on chromosome ten; NSCLC: Non-small-cell lung cancer; FBS :Phosphate
buffered saline; MTT:3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide; PBS: Phosphate buffered saline; DMSO:Dimethyl
sulfoxide; PI: Propidium iodide.
Introduction
Lung cancer is the most common cause of cancer-related death in men and women, and is responsible for 1.4 million deaths each year, and
has a tremendous impact on human health (Liao et al.,2007; Jemal et al.,2006). Non-small-cell lung cancer (NSCLC) accounts for about 80-85%
of all types of lung cancer, including large-cell carcinomas, squamous cell carcinoma and adenocarcinoma (D'Addario et al., 010). NSCLC is
usually treated with surgery accompanied with chemotherapy or radiation therapy at early stage (Pil et al., 2013). However, there are no very
effective therapies for lung cancer patients at late stage. It is urgent to find other novel therapy for lung cancer patients.
Opuntia dillenii Haw was introduced from Milpa region into China in 1997. Because its rhizome is an excellent herb medicine, it has been
used extensively for treatments of wounds, burns, asthma and diabetes (Huang et al., 2009). This plant contains high levels of nutrients, such as
polysaccharides, flavonoids (Zhao et al., 2011). Opuntia dillenii polysaccharides have been reported to display neuoprotective and antioxidative
effects (Huang et al., 2009). However, whether cactus polysaccharides from Opuntia dillenii have anti-tumor activities and what kind of
molecular mechanisms involved are still unclear. Therefore, this study was designed to examine the effect of cactus polysaccharides on lung
squamous carcinoma cells SK-MES-1 to provide evidence for developing novel drug.
Materials and Methods
Cell culture, antibodies and reagents
Human lung squamous carcinoma cells SK-MES-1 was from American Type Culture Collection (ATCC) and cultured in RPMI 1640
medium (Thermo,USA) supplemented with 10% Fetal bovine serum (FBS) (Thermo,USA), 100μg/ml penicillin and 100μg/ml streptomycin. 
Antibodies to p53, PTEN and β-actin were from Boster Biological Technology Wuhan, China.3-(4,5-Dimethylthiazol-2-yl)-2,5 -diphenyltetraz- 
olium bromide (MTT) was from Amresco, USA.
Preparation of cactus polysaccharides
Fresh Opuntia dillenii were collected from Lvshun, Dalian City, Liaoning Province, China. Extracts were prepared by removing the thorns
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and then soaking in distilled water 10 times at 80‐ for 2h. The supernatant was collected and concentrated by a rotary evaporator at 50‐ with 
pressure of 80 Mbar. Crude Cactus polysaccharides were precipitated by 95% ethanol at 4‐ and collected by centrifugation (1810×g, 20min) and 
freeze-drying. Cactus polysaccharides were dissolved in 0.2 mol/L Phosphate buffered saline (PBS) (pH7.4) and stored at 4‐. 
In vitro cell proliferation assay
Cells were seeded into 96-well plates and treated with gradient concentration of cactus polysaccharides (1.44 mg/ml, 0.72 mg/ml,
0.36mg/ml, 0.18 mg/ml, 0.09 mg/ml, 0.045 mg/ml, 0.0225 mg/ml, 0.01125 mg/ml and 0.005625mg/ml). After 24h or 48h cactus polysaccharides
treatment, 20μl MTT (5 mg/ml) was added to each well and incubated for 4 hours. Then 100μl Dim ethyl sulfoxide (DMSO) was then added into 
each well and the plates. The absorbance (Abs) of the individual wells was detected at the wavelength of 492 nm using microplate reader (Thermo,
USA). The inhibiting rate of the cells was determined by the following equation: inhibiting rate (%) = (1-Abs test /Abs cont)×100%.
Morphology test
SK-MES-1 cells were seeded into each flask at appropriate densities (1×105 cells /ml) and treated with different concentrations of cactus
polysaccharides (0.36 mg/ml, 0.18mg/ml) for 24h and 48h. The morphology changes were examined with phase contrast microscope (Nikon,
Japan).
Cell cycle and apoptosis analysis
For cell cycle analysis, SK-MES-1 cells were treated with different final concentrations of cactus polysaccharides solution (0.18 or
0.36mg/ml) compared to the control group treated with PBS. All groups were cultured for 24h and the cell pellets were collected by centrifugation
for 5min at 1000rpm. The pellet was washed twice with PBS and then added with 50μl (lmg/ml) propidium iodide (PI) and 5μl (10mg/ml) 
DNase-free RNase for 30min-60min at 40‐ without light. The cell cycle was detected by flow cytometry and analyzed by the system of 
Macintosh (Apple Inc. USA). For Annexin V assay, cactus polysaccharides treated cells were stained using an AnnexinV-FITC/PI Apoptosis
Detection Kit (BD Biosciences Pharmingen, SanDiego, California, USA) according to standard protocol. The Annexin positive cells apoptosis
were quantified flow cytometry and analyzed by Cell Quest Pro software (BD Biosciences Pharmingen, SanDiego, California, USA).
Western-blotting analysis
Cells treated with 0.36, 0.18mg/ml of cactus polysaccharides for 24h were collected by centrifugation at 4000rpm for 5 min at 4°C. Protein
extracts and Western blotting was carried out as described (Singhal et al., 2005). P53 was detected using rabbit polyclonal antibody (Boster, China,
1:500 dilution), PTEN was detected using rabbit polyclonal antibody (Boster, China, 1:1000 dilution). β-actin was used as the internal control 
(Boster, China, 1:1000 dilution). The protein bands detected by antibodies were visualized by Super signal West Pico ECL (Thermo Fisher Pierce,
USA).
Statistical analysis
Data were expressed as mean ± SD. Statistical Package for the Social Sciences (SPSS) 11.5 software was used for all statistical analysis of
data. One-way Analysis of Variance (ANOVA) analysis of variance was used to determine the significance in two comparisons. Statistical
significance was set at P<0.05.
Results
Cactus polysaccharides inhibits proliferation of human lung squamous carcinoma cells
The inhibiting effect of cactus polysaccharides on the lung squamous carcinoma cells was detected by MTT assay for 24h and 48h. Cactus
polysaccharides significantly inhibited cellular proliferation of the lung squamous carcinoma cells. The results showed that the inhibited rate of
SK-MES-1 cells treated with cactus polysaccharides in a concentration and time dependent manner (P <0.01) (Fig. 1).
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Figure 1: Effect of cactus polysaccharides on proliferation of lung cancer cells SK-MES-1 cells were treated with cactus polysaccharides
(1.44 mg/ml, 0.72 mg/ml, 0.36mg/ml, 0.18 mg/ml, 0.09 mg/ml, 0.045 mg/ml, 0.0225 mg/ml, 0.01125 mg/ml, 0.005625mg/ml) for 24h and
48h. The inhibiting rate of the cell growth was determined by MTT assay and expressed using the following equation: inhibiting rate (%) =
(1-Abs test /Abs cont)×100%. *, P<0.05. **, P<0.01.
Morphological changes of SK-MES-1 cells
Cells were treated with different concentrations of cactus polysaccharides 0.36 mg/ml and 0.18mg/ml for 24h and 48h. The morphological
changes of SK-MES-1 cells treated with cactus polysaccharides were detected by microscope. Compared to the control group, the cells were
arranged from thickness to dispersion and fuzzy (Fig. 2).
Figure 2: Effect of cactus polysaccharides on morphology of lung cancer cells SK-MES-1 cells were treated with cactus polysaccharides
(0.18mg/ml and 0.36mg/ml) for 24h and 48h. The shape of cells was observed by phase contrast microscope. The cells treated with Cactus
Polysaccharides were dispersion and fuzzy.
Cell cycle arrest and apoptosis induced by cactus polysaccharides treatment
We detected whether cactus polysaccharides could change the cell cycle and induce apoptosis. Therefore, we evaluated the effect of
different dose of cactus polysaccharides exposure on the cell cycle progression of SK-MES-1 cells. The results showed that there was no
significant difference in G1 phase among the control, low and high dose groups. However, cactus polysaccharides caused cells to accumulate in S
phase and reduce in G2 phase (Table 1). It suggested that cactus polysaccharides blocked SK-MES-1 cells in S phase. We then detected apoptosis
of cactus polysaccharides treated cells by Annexin V/PI staining. Our data showed that a steady increase in Annexin-positive cells to 31.15% in
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high dose group (Fig. 3).
Table 1: Effect of cactus polysaccharides on the cell cycle.
After treated with Cactus Polysaccharides (0.18 mg/ml, 0.36 mg/ml) for 24h, the cells were harvested and stained with propidium iodide, and the
proportion of cells in each phase of cell cycle was assayed.
Figure 3: Effect of cactus polysaccharides on apoptosis of lung cancer cells SK-MES-1 cells were treated with 0, 0.18 and 0.36 mg/ml of cactus
polysaccharides for 24h. Then they were stained with annexin-V-FITC and propidium iodide and analyzed by flow cytometry. Lower left
quadrant area indicated that the survival cells. The early and late apoptosis cells were presented by the lower right and upper right quadrants,
respectively.
P53 and PTEN expression levels in SK-MES-1
The cell cycle is composed of many steps which are regulated by a lot of factors. P53 is one of most important negatively regulators of
cell cycle. Mutation and alteration of P53 can lead to cancer (Levine et al., 1991). The study showed that P53 often inactivated in NSCLC. The
increased expression of p53 can induce cell cycle arrest and cause apoptosis (Singhal et al., 2005). To further investigate the mechanisms
underlying the cell cycle arrest and apoptosis induced by cactus polysaccharides, we detected the expression amount of P53 in the cells treated
with cactus polysaccharides. The expression of p53 in the high dose cactus polysaccharides group (0.36mg/ml) and low dose cactus
polysaccharides group (0.18mg/ml) were 3.83-fold and 1.99-fold increase than that of control group (Fig. 4).
PTEN is a kind of tumor-suppressor gene which has the dual-specificity phosphatase and plays an important role in both regulating the
cell growth and inducing the cell apoptosis (Weng et al.,2001). To further investigate the mechanisms underlying the cell cycle arrest and
apoptosis induced by cactus polysaccharides, we detected PTEN expression in the cells treated with cactus polysaccharides as well. Our data
showed that the expression of PTEN in high dose cactus polysaccharides group (0.36mg/ml) and low dose cactus polysaccharides group
(0.18mg/ml) were 2.61-fold and 3.59-fold increase than that of control group (Fig. 4).
Dose（mg/ml） Cell cycle（%）
G1 S G2
0.00 46.11 41.50 12.38
0.18 46.13 44.68 9.18
0.36 47.98 51.65 0.38
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Figure 4: Effect of cactus polysaccharides on P53 and PTEN expression SK-MES-1 cells were treated with 0, 0.18 and 0.36mg/ml of Cactus
Polysaccharides for 24h. Protein from the total cell lysate was subjected to western-blotting analysis for P53 and PTEN protein. PTEN and p53
were expressed relative to β-actin level and nomalized to control group. Representative results are shown from three independent experiments. 
Discussion
Polysaccharide components of some fork medicine had anti-tumor effects and can stimulate immune response (Chen et al.,2014; Sun et
al.,2011). Opuntia dillenii was a famous plant originating from Milpa characterized by high amounts of polysaccharides and water (Chang et al.,
2008). Opuntia dillenii polysaccharides could enhance the immune function of immunosuppressed mice and had a good antiocidant activity (Zhao
et al., 2012; Yang et al.,2013). However, there were no studies about anti-tumour effects of cactus polysaccharides on lung cancer. In this study,
we detected the effects of cactus polysaccharides from Opuntia dillenii on lung squamous carcinoma cells in vitro.
The results revealed that cactus polysaccharides inhibited the proliferation of lung squamous carcinoma SK-MES-1 cells in a concentration
and time dependent manner. Report had been indicated polysaccharides extracted from cactus pear fruit inhibited tumor growth in S180-bearing
mice by inducing apoptosis, increasing anti-oxidation and promoting immune responses (Liang et al., 2008). Considering most of polysaccharides
with non-toxic effects (Zong et al., 2012), the cactus polysaccharides could be an effective therapeutics without serious side-effects for lung
cancer patients.
We further detected the mechanisms of inhibiting effect of cactus polysaccharides on the growth of lung cancer cells. Our data showed that the
cactus polysaccharides inhibited proliferation of lung squamous carcinoma SK-MES-1 cells through inducing S phase arrest and triggering
apoptosis. Insight into molecular mechanisms indicated that the cactus polysaccharides could significantly increased P53 and PTEN expression,
which were negatively regulated cell cycle and induced apoptosis in the lung cancer cells.
In conclusion, our study is the first one to identify anti-tumor affects of cactus polysaccharides on lung squamous carcinoma cells. Our data
generate evidences for further evaluation of cactus polysaccharides as a new drug for lung cancer. The molecular mechanisms of wild cactus
polysaccharides preventing cell proliferation need further investigation.
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